SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Year-over-year revenue growth rate
Latest
0.00%
↓ 100% vs avg
Percentile
P60
Within normal range
Average
42.44%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 0.00% |
| Q3 2025 | 0.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | -100.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | -100.00% |
| Q2 2024 | -72.14% |
| Q1 2024 | 209.69% |
| Q4 2023 | -75.93% |
| Q3 2023 | 1381.56% |
| Q2 2023 | -85.28% |
| Q1 2023 | -73.11% |
| Q4 2022 | -39.80% |
| Q3 2022 | -43.47% |
| Q2 2022 | -46.20% |
| Q1 2022 | 6.74% |
| Q4 2021 | -24.67% |
| Q3 2021 | -19.38% |
| Q2 2021 | 7.57% |
| Q1 2021 | -34.27% |
| Q4 2020 | 0.00% |